PCRXbenzinga

Pacira BioSciences Q4 Adj $0.91 Beats $0.84 Estimate, Sales $187.25M Beat $184.36M Estimate

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on February 27, 2025 by benzinga

    Pacira BioSciences Q4 Adj $0.91 Beats $0.84 Estimate, Sales $187.25M Beat $184.36M Estimate | PCRX Stock News | Candlesense